l General Information |
Product Name | Carteolol HCl |
General description | Carteolol HCl is a β-adrenoceptor antagonist, used for the treatment of glaucoma. |
Synonym | 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one; hydrochloride |
Purity | ≥99.0%(HPLC) | CAS Number | 51781-21-6 |
Formula | C16H25ClN2O3 | Molecular Weight | 328.837 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥50mg/ml |
Water | ≥50mg/ml |
l Biological Information |
Biochem/Physiol
Actions | Carteolol Hydrochloride is a synthetic quinolinone derivative, antihypertensive Carteolol Hydrochloride is a nive beta-adrenoceptor blocking agent for beta-1 and beta-2 receptors with no membrane-stabilizing activity but moderate intrinsic sympathomimetic effects. It is used for treatment of hypertension and certain arrhythmias, and as an anti-angina and antiglaucoma agent. |
Application | 1.Anti-Arrhythmia Agents 2.Sympatholytics 3.Antihypertensive Agents 4.Adrenergic beta-Antagonists |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
